Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-047278

President & CSO sold 1,477 shares at $15.00 ($22,155)

  • President & CSO acquired 1,477 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shacham Sharon · President & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-17 Exercise or conversion : show line 1 in the form +1,477 $0.03 $49 757,966 D
2020-08-17 Sale : show line 2 in the form −1,477 $15.00 $22,155 756,489 D
Open-market sales · 1,477 sh · avg $15.00 · $22,155

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-08-17 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −1,477 $0.03 2020-10-31 1,477 6,076 D
Loading xslF345X03/doc4.xml…